1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DDX46 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA REXO1 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA CD109 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA TBC1D4 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA GTF2F2 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA CTRB2 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA AL022067.1 CTRPv2 pan-cancer AAC 0.082 0.01
mRNA CHCHD7 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA SPAG9 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA TNFRSF1A CTRPv2 pan-cancer AAC -0.088 0.01
Download CSV